Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Carrier Screening Market, by Type
1.4.2 Europe Carrier Screening Market, by Technology
1.4.3 Europe Carrier Screening Market, by End User
1.4.4 Europe Carrier Screening Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2017, Jun – 2021, Jun) Leading Players
Chapter 4. Europe Carrier Screening Market by Type
4.1 Europe Expanded Carrier Screening Market by Country
4.2 Europe Targeted Disease Carrier Screening Market by Country
Chapter 5. Europe Carrier Screening Market by Technology
5.1 Europe DNA Sequencing Market by Country
5.2 Europe Microarrays Market by Country
5.3 Europe Polymerase Chain Reaction Market by Country
5.4 Europe Other Technologies Market by Country
Chapter 6. Europe Carrier Screening Market by End user
6.1 Europe Hospital and Clinics Market by Country
6.2 Europe Physician Offices Market by Country
6.3 Europe Reference Laboratories Market by Country
6.4 Europe Other End user Market by Country
Chapter 7. Europe Carrier Screening Market by Country
7.1 Germany Carrier Screening Market
7.1.1 Germany Carrier Screening Market by Type
7.1.2 Germany Carrier Screening Market by Technology
7.1.3 Germany Carrier Screening Market by End user
7.2 UK Carrier Screening Market
7.2.1 UK Carrier Screening Market by Type
7.2.2 UK Carrier Screening Market by Technology
7.2.3 UK Carrier Screening Market by End user
7.3 France Carrier Screening Market
7.3.1 France Carrier Screening Market by Type
7.3.2 France Carrier Screening Market by Technology
7.3.3 France Carrier Screening Market by End user
7.4 Russia Carrier Screening Market
7.4.1 Russia Carrier Screening Market by Type
7.4.2 Russia Carrier Screening Market by Technology
7.4.3 Russia Carrier Screening Market by End user
7.5 Spain Carrier Screening Market
7.5.1 Spain Carrier Screening Market by Type
7.5.2 Spain Carrier Screening Market by Technology
7.5.3 Spain Carrier Screening Market by End user
7.6 Italy Carrier Screening Market
7.6.1 Italy Carrier Screening Market by Type
7.6.2 Italy Carrier Screening Market by Technology
7.6.3 Italy Carrier Screening Market by End user
7.7 Rest of Europe Carrier Screening Market
7.7.1 Rest of Europe Carrier Screening Market by Type
7.7.2 Rest of Europe Carrier Screening Market by Technology
7.7.3 Rest of Europe Carrier Screening Market by End user
Chapter 8. Company Profiles
8.1 Quest Diagnostics, Incorporated
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Recent strategies and developments:
8.1.2.1 Partnerships, Collaborations, and Agreements:
8.1.2.2 Product Launches and Product Expansions:
8.1.2.3 Acquisition and Mergers:
8.2 Thermo Fisher Scientific, Inc.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 Illumina, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Acquisition and Mergers:
8.4 Eurofins Scientific Group
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Recent strategies and developments:
8.4.4.1 Partnerships, Collaborations, and Agreements:
8.4.4.2 Acquisition and Mergers:
8.5 Invitae Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.5.5.2 Acquisition and Mergers:
8.6 OPKO Health, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Acquisition and Mergers:
8.7 Fulgent Genetics
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Acquisition and Mergers:
8.8 Sema4 OpCo, Inc.
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Partnerships, Collaborations, and Agreements:
8.8.2.2 Product Launches and Product Expansions:
8.9 Myriad Genetics, Inc.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Product Launches and Product Expansions:
8.1 Natera Inc.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
Unique Offerings 